{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:15:49Z","timestamp":1780323349904,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim Care Resp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COPD symptoms show a diurnal variability. However, morning and night variability has generally not been taken into consideration in disease management plans. The aims of this study were to cross-sectionally assess morning and night symptom prevalence and correlation with health status and disease severity in COPD, and to determine to what extent they could predict longitudinal outcomes, exacerbations and health status. A further aim is to explore whether the CCQ is able to depict this morning\/night symptomatology. We included 2,269 primary care COPD patients (58% male, 49% current smokers, with a mean age of 65\u00b111 years) from a Dutch Asthma\/COPD service. Spirometry, patient history, the Clinical COPD Questionnaire(CCQ) and the Asthma Control Questionnaire(ACQ) were assessed; we used the latter to evaluate morning (question 2) and night symptoms (question 1). A total of 1159 (51.9%) patients reported morning symptoms (ACQ question 2&gt;0) and 879 (39.4%) had night complaints (ACQ question 1&gt;0). Patients with morning\/night symptoms were mostly smokers and had on average poorer lung function, higher CCQ scores and used more rescue inhalers (<jats:italic>P<\/jats:italic>&lt;0.0001). Patients using long-acting muscarinic antagonists (LAMAs) had less night symptoms, showing a possible favourable effect. Only a small proportion of stable or slightly unstable patients (CCQ total scores &lt;2) had severe morning symptoms (ACQ 2\u2a7e4: <jats:italic>n<\/jats:italic>=19, 1.1%) or severe night symptoms (ACQ 1\u2a7e4: <jats:italic>n<\/jats:italic>=11, 0.7%). Night symptoms seemed to predict future exacerbations; however, baseline exacerbations were the strongest predictors (<jats:italic>n<\/jats:italic>=346, OR:4.13, CI: 2.45\u22126.95, <jats:italic>P<\/jats:italic>&lt;0.000). Morning symptoms increased the odds of poor health status at follow-up (<jats:italic>n<\/jats:italic>=346, OR:12.22, CI:4.76\u221231.39, <jats:italic>P<\/jats:italic>&lt;0.000). Morning and night symptoms in COPD patients are common, and they are associated with poor health status and predicted future exacerbations. Our study showed that patients with morning\/night symptoms have higher scores in CCQ, and therefore we do not really miss patients with high morning\/night symptomatology when we only measure CCQ. Severe morning symptoms predicted worsening of COPD health status.<\/jats:p>","DOI":"10.1038\/npjpcrm.2016.40","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T17:38:41Z","timestamp":1469122721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG"],"prefix":"10.1038","volume":"26","author":[{"given":"Ioanna","family":"Tsiligianni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Metting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thys","family":"van der Molen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-9199","authenticated-orcid":false,"given":"Niels","family":"Chavannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2760-0693","authenticated-orcid":false,"given":"Janwillem","family":"Kocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"key":"BFnpjpcrm201640_CR1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis Management and prevention of COPD. 2014. Update. Available at http:\/\/www.goldcopd.org\/ (assessed February 2015)."},{"key":"BFnpjpcrm201640_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall, J. C. et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54, 581\u2013586 (1999).","journal-title":"Thorax"},{"key":"BFnpjpcrm201640_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones, P. W. et al. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 34, 648\u2013654 (2009).","journal-title":"Eur. Respir. J."},{"key":"BFnpjpcrm201640_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-1-13","volume":"1","author":"T van der Molen","year":"2003","unstructured":"van der Molen, T. et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual. Life Outcomes 1, 13 (2003).","journal-title":"Health Qual. Life Outcomes"},{"key":"BFnpjpcrm201640_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/COPD.S29868","volume":"7","author":"AJ Cave","year":"2012","unstructured":"Cave, A. J., Atkinson, L., Tsiligianni, I. G. & Kaplan, A. G. Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int. J. Chron. Obstruct. Pulmon. Dis. (2012); 7, 447\u2013456.","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"BFnpjpcrm201640_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1183\/09059180.00004311","volume":"20","author":"A Agusti","year":"2011","unstructured":"Agusti, A. et al. Night-time symptoms: a forgotten dimension of COPD. Eur. Respir. Rev. 20, 183\u2013194 (2011).","journal-title":"Eur. Respir. Rev."},{"key":"BFnpjpcrm201640_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1183\/09031936.00051110","volume":"37","author":"R Kessler","year":"2011","unstructured":"Kessler, R. et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur. Respir. J. 37, 264\u2013272 (2011).","journal-title":"Eur. Respir. J."},{"key":"BFnpjpcrm201640_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1185\/03007995.2013.857648","volume":"30","author":"P O'Hagan","year":"2014","unstructured":"O'Hagan, P. & Chavannes, N. H. The impact of morning symptoms on daily activities in chronic obstructive pulmonary disease. Curr. Med. Res. Opin. 30, 301\u2013314 (2014).","journal-title":"Curr. Med. Res. Opin."},{"key":"BFnpjpcrm201640_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1164\/ajrccm.159.4.9703106","volume":"159","author":"GJJ Borsboom","year":"1999","unstructured":"Borsboom, G. J. J. et al. Diurnal variation in lung function in subgroups from two Dutch populations. Am. J. Respir. Crit. Care Med. 159, 1163\u20131171 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnpjpcrm201640_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/thorax.58.10.855","volume":"58","author":"PM Calverley","year":"2003","unstructured":"Calverley, P. M. et al. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 58, 855\u2013860 (2003).","journal-title":"Thorax"},{"key":"BFnpjpcrm201640_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.arbres.2011.07.004","volume":"48","author":"MJ Espinosa de los Monteros","year":"2012","unstructured":"Espinosa de los Monteros, M. J., Pe\u00f1a, C., Soto Hurtado, E. J., Jare\u00f1o, J. & Miravitlles, M. Variability of respiratory symptoms in severe COPD. Arch. Bronconeumol. 48, 3\u20137 (2012).","journal-title":"Arch. Bronconeumol."},{"key":"BFnpjpcrm201640_CR12","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1185\/03007990903103006","volume":"25","author":"MR Partridge","year":"2009","unstructured":"Partridge, M. R., Karlsson, N. & Small, I. R. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr. Med. Res. Opin. 25, 2043\u20132048 (2009).","journal-title":"Curr. Med. Res. Opin."},{"key":"BFnpjpcrm201640_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12931-014-0122-1","volume":"15","author":"M Miravitlles","year":"2014","unstructured":"Miravitlles, M. et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir. Res. 15, 122 (2014).","journal-title":"Respir. Res."},{"key":"BFnpjpcrm201640_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1183\/09031936.00123709","volume":"36","author":"M Partridge","year":"2010","unstructured":"Partridge, M. et al. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur. Respir. J. 36, 96\u2013104 (2010).","journal-title":"Eur. Respir. J."},{"key":"BFnpjpcrm201640_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3904\/kjim.2012.27.4.426","volume":"27","author":"YJ Kim","year":"2012","unstructured":"Kim, Y. J. et al. Patient's perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL study. Korean J. Intern. Med. 27, 426\u2013435 (2012).","journal-title":"Korean J. Intern. Med."},{"key":"BFnpjpcrm201640_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/COPD.S42866","volume":"8","author":"JL Lopez-Campos","year":"2013","unstructured":"Lopez-Campos, J. L., Calero, C. & Quintana-Gallego, E. Symptom variability in COPD: a narrative review. Int. J. Chron. Obstruct. Pulmon. Dis. 8, 231\u2013238 (2013).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"BFnpjpcrm201640_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1465-9921-14-112","volume":"14","author":"N Roche","year":"2013","unstructured":"Roche, N., Chavannes, N. H. & Miravitlles, M. COPD symptoms in the morning: impact, evaluation and management. Respir. Res. 14, 112 (2013).","journal-title":"Respir. Res."},{"key":"BFnpjpcrm201640_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3109\/15412555.2013.844784","volume":"10","author":"N Roche","year":"2013","unstructured":"Roche, N., Small, M., Broomfield, S., Higgins, V. & Pollard, R. Real world COPD: association of morning symptoms with clinical and patient reported outcomes. COPD 10, 679\u2013686 (2013).","journal-title":"COPD"},{"key":"BFnpjpcrm201640_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2147\/COPD.S48570","volume":"8","author":"D Price","year":"2013","unstructured":"Price, D. et al. Impact of night-time symptoms in COPD: a real-world study in five European countries. Int. J. Chron. Obstruct. Pulmon. Dis. 8, 595\u2013603 (2013).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"BFnpjpcrm201640_CR20","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1183\/09031936.00196713","volume":"43","author":"P Lange","year":"2014","unstructured":"Lange, P., Marott, J. L., Vestbo, J. & Nordestgaard, B. G. Prevalence of night-time dyspnoea in COPD and its implications for prognosis. Eur. Respir. J. 43, 1590\u20131598 (2014).","journal-title":"Eur. Respir. J."},{"key":"BFnpjpcrm201640_CR21","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1183\/09031936.00045614","volume":"43","author":"E Crisafulli","year":"2014","unstructured":"Crisafulli, E. Predicting poor prognosis in COPD patients: looking for a lamp lit in the darkness of the night. Eur. Respir. J. 43, 1560\u20131562 (2014).","journal-title":"Eur. Respir. J."},{"key":"BFnpjpcrm201640_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.sleep.2011.12.007","volume":"13","author":"TA Omachi","year":"2012","unstructured":"Omachi, T. A. et al. Katz PP.Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 13, 476\u2013483 (2012).","journal-title":"Sleep Med."},{"key":"BFnpjpcrm201640_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.sleep.2012.02.001","volume":"13","author":"BD Kent","year":"2012","unstructured":"Kent, B. D., McNicholas, W. T. & Verbraecken, J. Disturbed sleep and COPD outcomes: cart meets horse. Sleep Med. 13, 453\u2013454 (2012).","journal-title":"Sleep Med."},{"key":"BFnpjpcrm201640_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.rmed.2008.03.004","volume":"102","author":"F Pitta","year":"2008","unstructured":"Pitta, F. et al. Relationship between pulmonary function and physical activity in daily life in patients with COPD. Respir. Med. 102, 1203\u20131207 (2008).","journal-title":"Respir. Med."},{"key":"BFnpjpcrm201640_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/COPD.S15666","volume":"6","author":"SM Scharf","year":"2010","unstructured":"Scharf, S. M. et al. Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 1\u201312 (2010).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"BFnpjpcrm201640_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5665\/sleep.1698","volume":"35","author":"R Budhiraja","year":"2012","unstructured":"Budhiraja, R. et al. Insomnia in patients with COPD. Sleep 35, 369\u2013375 (2012).","journal-title":"Sleep"},{"key":"BFnpjpcrm201640_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1164\/rccm.200408-1054OC","volume":"171","author":"GC Donaldson","year":"2005","unstructured":"Donaldson, G. C., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R. & Wedzicha, J. A. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir. Crit. Care Med. 171, 446\u2013452 (2005).","journal-title":"Am J Respir. Crit. Care Med."},{"key":"BFnpjpcrm201640_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst, J. R. et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 363, 1128\u20131138 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnpjpcrm201640_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1477-7525-11-104","volume":"11","author":"A Hareendran","year":"2013","unstructured":"Hareendran, A. et al. The development ofa patient reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease. Health Qual. Life Outcomes 11, 104 (2013).","journal-title":"Health Qual. Life Outcomes"},{"key":"BFnpjpcrm201640_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1753465809344870","volume":"3","author":"MR Partridge","year":"2009","unstructured":"Partridge, M. R., Schuermann, W., Beckman, O., Persson, T. & Polanowski, T. Effect on lung function and morning activities of budesonide\/formoterol versus salmeterol\/fluticasone in patients with COPD. Ther. Adv. Respir. Dis. 3, 1\u201311 (2009).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"BFnpjpcrm201640_CR31","doi-asserted-by":"publisher","first-page":"14101","DOI":"10.1038\/npjpcrm.2014.101","volume":"25","author":"EI Metting","year":"2015","unstructured":"Metting, E. I. et al. Feasibility and effectiveness of an Asthma\/COPD service for primary care: a cross-sectional baseline description and longitudinal results. NPJ Prim. Care Respir. Med. 25, 14101 (2015).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"BFnpjpcrm201640_CR32","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","volume":"14","author":"EF Juniper","year":"1999","unstructured":"Juniper, E. F., O'Byrne, P. M., Guyatt, G. H., Ferrie, P. J. & King, D. R. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 14, 902\u2013907 (1999).","journal-title":"Eur. Respir. J."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201640.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201640","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201640.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:18:05Z","timestamp":1672834685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,1]]}},"alternative-id":["BFnpjpcrm201640"],"URL":"https:\/\/doi.org\/10.1038\/npjpcrm.2016.40","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]},"assertion":[{"value":"12 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IT, NC and JK are associate editors of npj Primary Care Respiratory Medicine, but were not involved in the editorial review of, nor the decision to publish this article. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16040"}}